1.. INTRODUCTION {#s1}
================

Demographic transition has reached Lebanon before any other Arab country, with the percentage (7.4%) of Lebanese elderly people aged 65 years or more being the highest in the region \[[@B1],[@B2]\]. The functional status decline is one of the major complications elderly people may encounter. Different aspects of an elderly life can be affected by this decline. The implications range from a slight decrease in the quality of life at early stages to an increased demand of resources for care and rehabilitation, hospitalization or admission to residential care, and may even evolve to premature death. Thereby, prevention of disability in the elderly is a matter of humanitarian, economic, and public health concern \[[@B3]\]. Moreover, the development of adequate preventive strategies requires an understanding of the mechanisms behind the age-associated decline in the functional status \[[@B4]\].

Generally, disability can be the result of several factors coexisting in the disabled elderly. Predisposing factors of childhood (that might affect growth and development patterns, which influence muscle formation), followed by contributing factors (physical inactivity, chronic diseases, and malnutrition) during midlife \[[@B5]\], and some environmental changes (difficulty in accessing health services, difficulty leaving home because of architectural barriers, and based on whether signage on roads and walkways is sufficient/insufficient) \[[@B6]\], may develop in the advanced age into a larger spectrum of parameters such as sarcopenia, low income, social isolation, inadequate lifestyle habits, and medication use \[[@B7],[@B8]\]. Moreover, socioeconomic inequity and irregular access to healthcare make the situation more complicated in a transitional country such as Lebanon \[[@B9]\]. Although medications may be linked to disability, few studies have attempted to link disability to medication intake \[[@B10],[@B11]\].

The prevalence of prescribing medications to seniors has increased substantially over the past decade \[[@B12]\]. In fact, prescribed medications are an important contributor to the functional decline in the elderly \[[@B13]\]. In a prospective study of community-dwelling older adults, increased prescription medication use was associated with diminished ability to perform instrumental activities of daily living (ADLs) and reduced physical functioning \[[@B14]\]. Multiple potential physiological explanations exist to elucidate the impact of medication \[[@B15]\]. For example, it has been suggested that specific medication may increase the risk for impaired functional status by adversely affecting domains such as alertness, vision, and muscle strength with increased risk of falls and fractures \[[@B16]\]. In addition, potential prescribing problems exist among elderly with dosage, duplication, drug--drug interactions, duration, and drug--disease interactions \[[@B17],[@B18]\]. Therefore, prescribing for older people requires careful assessment of benefits and risks for the person's entire medical status \[[@B19]\]. However, drug classes do not have the same level of effect on the functional status. Some classes may have little or no effect; others may cause disability, whereas few drugs are believed to play a protective role \[[@B20]\]. Several studies have shown associations between exposure to certain classes of medications, particularly those with sedative and anti-cholinergic actions, and physical dysfunction in elderly \[[@B21],[@B22]\]. However, the number of medications used, regardless of their category, was associated with a decline in functional status in most studies \[[@B23]\].

Moreover, other than demographic features such as female sex and increasing age \[[@B24],[@B25]\], lifestyle features such as smoking and alcohol consumption, low education, low income, as well as urban dwelling have been associated with increased risk of disability among elderly persons \[[@B24],[@B26]\].

The Aging and Malnutrition in Elderly Lebanese (AMEL) study was primarily conducted to assess the health and nutritional status of community-living elderly people in rural settings in Lebanon \[[@B27]\]. In the present work, the AMEL study database was explored to spot functional disability-associated factors, especially those related to polypharmacy, alcohol consumption, and the nutritional status. To our knowledge, this is the first study describing the health conditions of a large representative sample of elderly Lebanese living in rural areas.

2.. METHODS {#s2}
===========

The AMEL is a cross-sectional, population-based study conducted between April 2011 and April 2012, including 1200 community-dwelling elderly individuals living in 24 rural Cazas (districts) of Lebanon. People aged ≥65 years were randomly selected through multistage cluster sampling. Subjects were interviewed at their homes by trained interviewers. A minimum of 1024 subjects was necessary to establish a 95% confidence interval, with an accuracy of ±3%, taking clustering into account. Due to possible missing values in several items, a final sample size of 1200 elderly persons was chosen.

2.1.. Subjects and Setting {#s2.1}
--------------------------

Lebanon is divided into Mohafazat (governorates), each of which consists of several districts (Cazas) forming a total of 25 Cazas. As our study targeted only rural elderly subjects, the Caza of Beirut (urban area) was excluded. In each of the remaining 24 Cazas (strata), two villages were randomly selected from the list of villages provided by the Central Agency for Statistics in Lebanon, except for two Cazas where only one large village was selected, giving a total of 46 villages.

Within each village, a random sample of 25 elderly individuals was drawn from the small villages and 50 from the larger villages, based on the list of households provided by the municipality or other local authority. The reason for not selecting the number of participants according to proportional allocation is that the number of subjects to be included per village was not known ahead of time due to the lack of data from government authorities; we sometimes had to visit each village and get the population list from the concerned municipality. The number of subjects to be included in each village was adjusted a posteriori. A replacement list was prepared in case of absence or refusal of participation. The inclusion criteria were: to be at least 65 years old, to live at home in rural areas, to be free from any terminal illness, and not be tube-fed.

2.2.. Tools and Techniques {#s2.2}
--------------------------

The study was based on a comprehensive multicomponent interview schedule including the assessment tools as described below. The interview schedule was translated back and forth from French to Arabic by two sworn translators. A pilot study including 100 individuals was performed previously to pretest the feasibility of the interview schedule.

The interview schedule was administered to the participants at their home by trained interviewers. Participants remained anonymous and individual records were kept confidential. The recorded variables included demographic characteristics (age, gender), living conditions (living alone or with others), financial situation, and medical insurance. Weight was measured in light indoor clothes without shoes, by electronic digital scale to the nearest 0.1 kg, whereas height was measured in a standing position to the nearest 0.1 cm. Body mass index (BMI) was computed as weight (kg)/height (m^2^). Nutritional status was assessed by the mini-nutritional assessment (18 questions score) in its Arabic version \[[@B28]\]. Comorbidities were recorded by asking participants whether they suffered from chronic physician-diagnosed conditions such as hypertension, diabetes, and so on. Drug intake was assessed by the number of drugs taken daily on a regular basis as prescribed by a physician, and checked with packages shown to the interviewer \[[@B27]\]. Polypharmacy was defined by the number of drugs greater than 6 per participant \[[@B29]\].

Furthermore, the participants were questioned about chronic pain (yes/no), defined as feeling pain for at least 3 months, insomnia (no or occasionally/often or always) as well as recent hospitalization (\<1 year). Some questions were dedicated to exploring dietary habits, tobacco, and alcohol consumption. Diets were based on the diseases the population declared to have; low-fat diet was defined as a diet to treat hypercholesterolemia and hypertriglyceridemia, whereas the diabetic diet was the diet people followed if they were diabetic. They were assessed by interviewers who were all nutritionists.

Depression was assessed by the 5-item Geriatric Depression Scale (GDS-5) \[[@B30]\], which was validated in its Arabic version \[[@B31]\]. The Lubben Social Network Scale 6 in its abbreviated version was used to investigate the social network \[[@B32],[@B33]\]. Finally, subjective loneliness was assessed by the modified version of the Jong Gierveld Loneliness Scale as described by Wilson et al. \[[@B34]\].

Among the different scales, the outcome variable studied was the result of the ADL score, which was computed by adding the answers to all the ADL questions, while the most potential explanatory variables were medication factors and health-related predictors. The ADL 5-item scale was used to assess the functional status. ADL is a tool commonly used in comprehensive geriatric assessment evaluating the basic activities such as bathing, toileting, clothing, walking, and eating on his/her own \[[@B35]\]. This scale was validated in its Arabic version by Nasser and Doumit \[[@B36]\] in a sample of Lebanese elderly living in nursing homes. Incontinence was not considered in this scale, because difficulties in bladder or bowel control reflect an abnormality in a particular physical system and should, therefore, be considered as impairment rather than a disability \[[@B37]\]. According to the results, participants were divided into two groups: those who are independent in all 5 items were considered "not disabled," and those who need help to accomplish at least one of the tasks of the score were defined as "disabled."

2.3.. Compliance with Ethical Standards {#s2.3}
---------------------------------------

The study was approved by the ethics committee of the Saint Joseph's University. Oral consent was obtained from participants before the administration of the interview schedule. Also, participants' identity and individual results were kept confidential.

2.4.. Statistical Analysis {#s2.4}
--------------------------

The Statistical Package for Social Sciences (SPSS) version 23.0 was used to enter and analyze data. Drugs taken by each participant were classified into drug classes and were recorded into new dichotomized variables. We used the Chi-square test in the bivariate analysis. Fisher's Exact, a non-parametric, alternative was used where applicable. Odds ratios with 95% confidence intervals were calculated. Dependent variable was the functional status dichotomized as "disabled" vs. "not disabled."

Due to the low sample size with regard to the high number of variables to be introduced within the multivariable model, multivariable logistic regression analysis was performed in five separate models: variables were grouped and analysis carried out for every group of independent variables. We introduced on each model the main independent variables that were associated with functional status at *p* ≤ 0.05 in the bivariate analysis. In model 1, all the sociodemographic predictors were introduced simultaneously. Model 2 included chronic diseases-related variables. In model 3, health and medication variables were entered. Model 4 included dietary habits, alcohol, and tobacco consumption were tested additionally. A final model (model 5: the summary) was run with all the variables that were significantly associated with functional status in the previous four models. In the final model, age and polypharmacy were enforced. Checking for interactions was performed on the associations between polypharmacy and ADL, before concluding to the final model: checking for interactions of medications was performed using stratified analysis (testing for OR homogeneity between strata) and introducing the interaction term in the regression model. The same predictors were introduced in a multiple regression model assuming ADL to be a continuous variable, after checking its validity using appropriate testing.

3.. RESULTS {#s3}
===========

A total number of 1200 participants was included in our analysis. Baseline characteristics of participants are detailed earlier \[[@B27]\]. The sample included 591 men (49.2%) and 609 women (50.8%). The mean age was 75.3 ± 7.1 years and similar in both genders. Nearly 60% of the participants were Christians, 27.7% were Muslims, and 13.7% Druze. About 10% of the elderly individuals lived alone; among these, elderly women were three times more likely to live alone than men. Most of the men (84.8%), but only 44.2% of women were still married. Women were two times more likely to be illiterate than men and to suffer from poor financial status. About 46.8% of the participants had a monthly income of less than 300,000 LL (USD 200), and two thirds were partially or totally dependent on their children. More than 40% of the study sample did not have any health insurance. Regarding the current work status, nearly 30% of men were still working.

3.1.. Prevalence of Disability {#s3.1}
------------------------------

The prevalence of disability in the sample was 24%, with 76% of the study participants being "independent" in terms of functional status. Besides, 287 (23.9%) elderly persons included in the study were found to be exposed to polypharmacy.

3.2.. Disability According to Sociodemographic Variables {#s3.2}
--------------------------------------------------------

Citizens of South Lebanon and Nabatieh were observed to have a higher proportion of disabled participants (South 32.2% and Nabatieh 32.0%) as compared with participants living in other governorates (*p* = 0.001). The percentage of disabled individuals was found to double in people older than 80 (18.6% if age \<80 vs. 41.1% if age ≥80. *p* = 0.001) and in those living with other individuals in the same house (13.45% if living alone and 25.2% if not. *p* = 0.004). Also, women are significantly more physically dependent than men (27.5% vs. 20.5% *p* = 0.005). Nevertheless, the "number of rooms at home" and "having a medical insurance" were not associated with the functional status ([Table 1](#T1){ref-type="table"}).

###### 

Percentages of "disabled participants" between different groups of sociodemographic variables

  **Variables**                                                 **Disabled**   **Not disabled**
  ------------------------------------------------------------- -------------- ------------------
  Governorate                                                   \<0.001        
    Mount Lebanon *n* = 300                                     66 (22%)       234 (78%)
    North Lebanon *n* = 300                                     53 (17.7%)     247 (82.3%)
    South Lebanon *n* = 150                                     48 (32.2%)     102 (67.8%)
  Nabatieh *n* = 200                                            64 (32.0%)     136 (68.0%)
  Bekaa *n* = 250                                               57 (22.8%)     197 (77.2%)
  Age                                                           \<0.001        
    \<80 years *n* = 910                                        169 (18.6%)    741 (81.4%)
    ≥80 years *n* = 290                                         119 (41.1%)    171 (58.9%)
  Sex                                                           0.005          
    Male *n* = 592                                              121 (20.5%)    471 (79.5%)
    Female *n* = 608                                            167 (27.5%)    441 (72.5%)
  Monthly income                                                0.029          
    \<600,000 LBP[^\*^](#TFN1){ref-type="table-fn"} *n* = 860   222 (25.7%)    638 (74.3%)
    \>600,000 LBP[^\*^](#TFN1){ref-type="table-fn"} *n* = 340   66 (19.4%)     274 (80.6%)
  Insurance/National security coverage                          0.667          
    No *n* = 492                                                122 (24.4%)    370 (75.6%)
    Yes *n* = 708                                               166 (23.4%)    542 (76.6%)
  Lives alone                                                   0.004          
    No *n* = 1080                                               272 (25.2%)    808 (74.8%)
    Yes *n* = 120                                               16 (13.5%)     104 (86.5%)
  Number of rooms at home                                       0.253          
    ≤3 rooms *n* = 514                                          115 (22.5%)    401 (77.5%)
    \>3 rooms *n* = 686                                         173 (25.4%)    513 (74.6%)

Equivalent to US\$400.

3.3.. Health Status and Biometric Variables {#s3.3}
-------------------------------------------

Participants who suffered "insomnia," "chronic pain," described their health status as "bad," were "losing weight involuntarily," "hospitalized" or "have been consulted by their doctor last year", were found to be more disabled than those who have not been in these circumstances (*p* = 0.001). Subjects with thin/normal BMI were at more risk of disability than their overweight fellows (disabled: 27.3% among thin/normal BMI, 21.0% among overweight *p* = 0.025). More disabled participants appear among depressive (45.1%) (vs. 18.1% among participants with normal GDS-5 results, *p* = 0.001) and lonely individuals (50.7%) (vs. 24.0% among patients with normal Wilson results, *p* = 0.001).

3.4.. Polypharmacy {#s3.4}
------------------

The increasing number of administered drugs was significantly associated with disability as there were more disabled people among participants consuming more than six drugs (polypharmacy) (40.8%) than among those consuming less than five (18.8%) (*p* \< 0.001). The class of medication taken had also an effect. Taking an atypical antipsychotic, Alzheimer, or Parkinson drug is associated with the highest proportions of disabled participants (66.7%, 77.9%, and 68.2%, respectively) ([Table 2](#T2){ref-type="table"}).

###### 

Percentages of disabled participants with respect to regular drug intake

  **Drug intake (Variables)**              **Yes/No**   ***n***      **Disabled (%)**   **Not disabled (%)**   ***p*-Value**[^a^](#TFN2){ref-type="table-fn"}
  ---------------------------------------- ------------ ------------ ------------------ ---------------------- ------------------------------------------------
  Polypharmacy                             No           622          117 (18.8)         505 (81.2)             
  Yes                                      419          171 (40.8)   248 (59.6)                                
  Diuretics                                No           936          203 (21.7)         733 (78.3)             \<0.001
  Yes                                      264          85 (32.2)    179 (67.8)                                
  Anti-arrhythmic                          No           951          222 (23.4)         729 (76.4)             0.035
  Yes                                      249          85 (34.2)    164 (65.8)                                
  Anti-coagulants                          No           802          170 (21.2)         632 (78.8)             \<0.001
  Yes                                      398          118 (29.6)   280 (70.4)                                
  Anti-ischemic                            No           1072         237 (22.1)         835 (77.9)             \<0.001
  Yes                                      128          51 (39.8)    77 (60.2)                                 
  Oral anti-diabetics                      No           901          191 (21.2)         710 (78.8)             \<0.001
  Yes                                      292          97 (33.2)    195 (66.8)                                
  Insulin                                  No           1178         278 (23.6)         900 (76.4)             0.018
  Yes                                      22           10 (45.5)    12 (54.5)                                 
  NSAID[^b^](#TFN3){ref-type="table-fn"}   No           986          216 (21.9)         770 (78.1)             \<0.001
  Yes                                      214          72 (33.6)    142 (66.4)                                
  PPI[^c^](#TFN4){ref-type="table-fn"}     No           1015         213 (21.0)         802 (79.0)             \<0.001
  Yes                                      185          74 (40.0)    111 (60.0)                                
  Laxatives                                No           1186         281 (23.7)         905 (76.3)             0.011
  Yes                                      12           7 (58.3)     5 (41.7)                                  
  Anti-cholinergic                         No           1170         272 (23.2)         898 (76.8)             \<0.001
  Yes                                      30           16 (53.3)    14 (46.7)                                 
  Vitamins supplements                     No           930          199 (21.4)         731 (78.6)             \<0.001
  Yes                                      270          89 (33.0)    181 (67.0)                                
  Anti-gout                                No           1161         265 (22.8)         896 (77.2)             \<0.001
  Yes                                      39           23 (59.0)    16 (41.0)                                 
  Typical/atypical antipsychotics          No           1191         282 (23.7)         909 (76.3)             0.008
  Yes                                      9            6 (66.7)     3 (33.3)                                  
  SSRI[^d^](#TFN5){ref-type="table-fn"}    No           1174         277 (23.6)         897 (76.4)             0.027
  Yes                                      26           11 (42.3)    15 (57.7)                                 
  Alzheimer drugs                          No           1191         281 (23.6)         900 (76.4)             \<0.001
  Yes                                      9            7 (77.9)     2 (82.1)                                  
  Parkinson drugs                          No           1178         286 (24)           905 (76)               \<0.001
  Yes                                      99           15 (68.2)    7 (31.8)                                  
  Muscle relaxants                         No           1184         278 (23.5)         906 (76.5)             \<0.001
  Yes                                      16           10 (62.5)    6 (37.5)                                  

Only variables significantly associated with disability were shown in this table;

Non steroidal anti-inflammatory drugs;

Proton pump inhibitors;

Specific serotonin reuptake inhibitors.

3.5.. Dietary Habits {#s3.5}
--------------------

The analysis has finally shown that any kind of "special diet" (low-fat, sodium-free, diabetic, low calories, fluid diet), smoking status, and alcohol consumption were significantly associated with a greater tendency toward disability (*p* = 0.001). Hence, 30.7% of smokers were disabled, whereas only 20.5% of nonsmokers were affected by a disability (*p* = 0.001). The greatest difference was observed between alcohol consumers (62.8% were dependent) and participants not drinking alcohol (19.5% were dependent) (*p* = 0.001) ([Table 3](#T3){ref-type="table"}).

###### 

Association of disability to diet types and lifestyle variables

  **Diet or habit**                   **Disability (%)**   **No disability (%)**   ***p*-Value**
  ----------------------------------- -------------------- ----------------------- ---------------
  Sodium-free diet *n* = 658          196 (29.8)           462 (70.2)              \<0.001
  No sodium-free diet *n* = 570       98 (17.2)            472 (82.8)              
  Low-fat diet *n* = 433              150 (34.6)           283 (65.4)              \<0.001
  No low-fat diet *n* = 763           135 (17.7)           628 (82.3)              
  Diabetes diet *n* = 444             153 (34.5)           291 (65.5)              \<0.001
  No diabetes diet *n* = 750          132 (17.6)           618 (82.4)              
  Low-calories diet *n* = 299         107 (35.8)           192 (64.2)              \<0.001
  No low-calories diet *n* = 894      178 (19.9)           716 (80.1)              
  Fluid diet *n* = 185                83 (44.9)            102 (55.1)              \<0.001
  No fluid diet *n* = 1010            202 (20.0)           808 (80.0)              
  Alcohol consumption *n* = 121       76 (62.8)            45 (37.2)               \<0.001
  No alcohol consumption *n* = 1072   209 (19.5)           863 (80.5)              
  Smoking *n* = 407                   125 (30.7)           282 (69.3)              \<0.001
  No smoking *n* = 790                162 (20.5)           628 (79.5)              

This table contains an exhaustive list of the factors that have entered the study from this section.

3.6.. Multivariable Analyses {#s3.6}
----------------------------

The multivariable analysis shows that citizens of Mount Lebanon (OR = 0.889; CI 0.466--1.815) or North (OR = 0.801; CI 0.338--1.545) had less disability, whereas living in South (OR = 1.785; CI 1.166--4.881) or in Nabatieh (OR = 2.395; CI 0.977--5.228) was associated with higher rates of dependence. Logistic regressions also showed that having some chronic diseases can be associated with an increased risk of being disabled; thus, any chronic disease is considered to be a risk factor toward functional status decline. "Skin ulcer" (OR = 8.660; CI 3.311--15.822) and "amputated member" (OR = 9.589; CI 3.158--20.147) were the chronic impairments that would increase disability the most. If we examine the effect of medications, we can see that when we performed the logistic regression on all drug classes, five remained in the equation: anti-ischemic, proton pump inhibitors (PPIs), laxatives, anti-gout, and antiparkinson medications. Antiparkinson medications were by far the class of medications that would increase disability the most (OR = 11.590; CI 5.699--23.277) ([Table 4](#T4){ref-type="table"}).

###### 

Impact of potential correlates on functional status (ADL): logistic regressions

                                                               ***B***   **Sig.**   **OR**   **95% CI for exp (*B*)**   
  ------------------------------------------------------------ --------- ---------- -------- -------------------------- --------
  Model 1: Chronic diseases                                                                                             
  Hypertension                                                 0.344     0.049      1.411    1.001                      1.988
  Diabetes                                                     0.479     0.005      1.614    1.154                      2.257
  Cardiac problem                                              0.357     0.047      1.429    1.005                      2.032
  Rheumatoid arthritis                                         0.326     0.093      1.385    0.947                      2.025
  Parkinson                                                    1.216     0.008      3.372    1.375                      8.268
  Gastric problem                                              0.783     \<0.001    2.188    1.480                      3.234
  Hearing impairment                                           0.772     \<0.001    2.163    1.511                      3.099
  Skin ulcer                                                   2.159     0.012      8.660    1.615                      46.437
  Amputation                                                   2.26      0.009      9.589    1.764                      52.122
  Hyperuricemia                                                0.878     0.033      2.405    1.074                      5.384
  Dementia                                                     1.126     \<0.001    3.083    1.635                      5.810
  Fracture                                                     0.762     0.005      2.142    1.259                      3.645
                                                                                                                        
  Model 2: Health status, biometric variables and medication                                                            
  Anti-ischemic                                                0.606     0.041      1.833    1.026                      3.276
  PPIs                                                         0.688     0.006      1.990    1.213                      3.265
  Laxatives                                                    1.679     0.075      5.360    0.846                      33.936
  Anti-gout                                                    1.201     0.025      3.324    1.165                      9.487
  Parkinson drugs                                              2.450     0.006      11.590   1.985                      67.668
  Insomnia                                                     0.476     0.026      1.610    1.059                      2.448
  Consults doctor                                              0.702     0.001      2.018    1.308                      3.112
  Depression                                                   0.566     0.013      1.761    1.124                      2.760
  Malnutrition                                                 1.026     \<0.001    2.789    1.769                      4.397
  Loneliness                                                   0.676     0.003      1.965    1.264                      3.055
                                                                                                                        
  Model 3: Diet and habits                                                                                              
  Smoking                                                      0.536     \<0.001    1.710    1.276                      2.290
  Smoking period                                               −0.428    0.009      0.652    0.474                      0.897
  Diabetic diet                                                0.419     0.014      1.520    1.089                      2.122
  Fluid diet                                                   0.413     0.060      1.512    0.983                      2.324
  Alcohol                                                      1.541     \<0.001    4.668    2.967                      7.344

Model 1: Omnibus test (*p* = 0.001), Hosmer/Lemshow (*p* = 0.549) tests and the classification table (77.1%) show that the model is adequate to reality and that at least one chronic disease has an effect on the functional status. Also, 22.8% (Nagelkerke *R*-square) of the variance of the functional status can be explained by chronic diseases. Model 2: Omnibus test (*p* = 0.001), Hosmer/Lemshow (*p* = 0.314) tests and the classification table (75.4%) show that the model is adequate to reality and that at least one variable has an effect on the functional status. Also, 31.4% (Nagelkerke *R*-square) of the variance of the functional status can be explained by the health status, biometric variables, and medication. Model 3: Omnibus test (*p* = 0.001), Hosmer/Lemshow (*p* = 0.955) tests and the classification table (79%) show that the model is adequate to reality and that at least one diet habit has an effect on the functional status. Also, 15.7% (Nagelkerke *R*-square) of the variance of the functional status can be explained by diet habits. In each model, the factors that were retained in the final model were exclusively displayed in the table; PPIs, proton pump inhibitors.

After checking for interactions with medications to be associated with disability, the interaction with "alcohol consumption," was found to be the only one responsible for a potential quantitative interaction influencing the relationship between "polypharmacy" and "disability"; results were found to be significant in both stratified analysis and logistic regression (when introducing the interaction term). This interaction was significant both on clinical and statistical levels (Homogeneity test: 0.020/RR1 = 2.421 \[1.742--3.364\]/RR2 = 8.432 \[3.002--23.686\]). Multivariate analysis was thus performed in strata ([Table 5](#T5){ref-type="table"}). Two items namely, "antiparkinson drugs" and "amputation" were excluded from the model for their extreme correlations. In fact, extreme correlation with other variables can lead to collinearity.

###### 

Summary logistic regression model: disability correlates among Lebanese elderly

  **Variables**              **Whole sample**   **Not drinking alcohol**                            
  -------------------------- ------------------ -------------------------- ------- -------- ------- -------
  Age                        1.066              \<0.001                    2.904   1.012    0.000   2.752
  Live alone                 −1.22              0.007                      0.295   −0.831   0.061   0.436
  Cerebrovascular  disease   --                 --                         --      0.500    0.063   1.648
  Rheumatoid arthritis       −0.538             0.074                      0.584   --       --      --
  Parkinson drugs            1.180              0.087                      3.253   --       --      --
  Gastric disease            0.561              0.071                      1.753   0.811    0.007   2.250
  Hearing impairment         0.447              0.088                      1.563   --       --      --
  Skin ulcer                 2.148              0.085                      8.569   2.174    0.083   8.795
  Dementia                   1.299              0.027                      3.667   1.364    0.015   3.911
  Fracture                   0.731              0.049                      2.077   0.793    0.055   2.209
  Polypharmacy               0.736              0.007                      2.087   --       --      --
  Proton pump inhibitors     0.549              0.075                      1.731   --       --      --
  Anti-gout                  1.377              0.032                      3.962   1.357    0.065   3.883
  Nutritional status         0.736              0.005                      2.088   0.589    0.026   1.803
  Loneliness                 0.559              0.026                      1.749   0.480    0.075   1.616
  Diabetes diet              0.422              0.098                      1.525   0.546    0.038   1.726
  Alcohol consumption        0.993              0.003                      2.698   --       --      --

Polypharmacy (OR = 2.087; CI 1.099--8.367), two drug classes namely, PPI \[OR = 1.731; CI 0.922--7.663; *p* value = 0.075) and anti-gout drugs \[OR = 3.962; CI 1.116--9.624\] and 16 other variables (most of them were chronic diseases) appeared in the final model of the entire sample. "Skin ulcer" had highly significant association (OR = 8.569; CI 5.330--14.823), followed by "Dementia" (OR = 3.667; CI 1.167--8.912) and "anti-gout drugs" (OR = 3.962; CI 1.290--7.622). The results were similar when regression was performed selectively on participants who did not drink alcohol with almost the same items and with similar OR values.

However, five items were removed from the second model (arthritis, Parkinson, hearing impairment, polypharmacy and PPI) and one new item was added (cerebrovascular disease OR = 1.648) ([Table 5](#T5){ref-type="table"}). Furthermore, when using ADL as a continuous variable, several factors that showed significance in the logistic regression remained significant in the multiple regression, namely, age, cerebrovascular disease, skin ulceration, dementia, fracture, polypharmacy, and diabetic diet were associated with lower ADL; living alone and having a better nutritional status with a higher ADL; whereas alcohol consumption had no significant effect on ADL ([Table 6](#T6){ref-type="table"}).

###### 

Multiple regression model: disability correlates among Lebanese elderly

  **Variables**             **Whole sample**            
  ------------------------- ------------------ -------- ---------
  Age                       −0.017             −0.121   \<0.001
  Live alone                0.281              0.085    \<0.001
  Cerebrovascular disease   −0.948             −0.136   \<0.001
  Skin ulcer                −0.687             −0.072   0.002
  Dementia                  −0.425             −0.091   \<0.001
  Fracture                  −0.233             −0.064   0.006
  Polypharmacy              −0.027             −0.083   0.001
  Nutritional status        0.098              0.428    \<0.001
  Diabetes diet             −0.123             −0.055   0.025
  Alcohol consumption       0.093              0.059    0.116

4.. DISCUSSION {#s4}
==============

According to our database findings, the prevalence of disability in Lebanese elderly is 24%. In 2012, disability occurred in 20.1% of the participants in a Japanese study directed by Yoshida et al. \[[@B38]\]. The percentage of polypharmacy among our study participants (24%) was found to be in line with the available literature where polypharmacy of the included elderly \[[@B39]--[@B41]\] in ambulatory settings and nursing homes ranged between 15% and 37%.

The association found between polypharmacy and the functional status decline acts through different hypothetical pathways. First, most people using more than six drugs suffer from multiple chronic diseases, which can be the actual predictor. Second, another possible mechanism can be explained by the frequent kidney and liver intoxication that can be induced by polypharmacy. Finally, some medications can alter the cognitive and brain balance centers and lead to fall risks and subsequent fractures. Polypharmacy has been and will always be a common problem that health care professionals face among the elderly population because of the multiple diseases that develop as the patient ages. Unfortunately, with this increase in the use of multiple medications comes an increased risk for negative health outcomes such as higher healthcare costs, ADEs, drug--drug interactions, medication non-adherence, decreased functional status, and geriatric syndromes. More efforts are needed to try to minimize the number of unnecessary drugs taken by the elderly \[[@B42]\].

However, the medication classes can be as important as the number of medications taken. According to our findings from the bivariate and multivariate analyses, anti-Alzheimer and antiparkinson drugs were the most associated medications with lower dependency. The association between "Parkinson drugs" and disability can be related to the dyskinesia they can cause on long-term use, especially with Levodopa; however, we cannot overlook the fact that the disease itself could be the reason of the disability, not the treatment (this is what we found in the multiple regression). Furthermore, "Alzheimer drugs" may be associated with the functional status decline through "Alzheimer disease."

For other factors, we will discuss multivariate results selectively. One of the most effective factors was found to be living in rural areas in the governorates of Nabatieh and South Lebanon. Indeed, several studies reported that elderly people living in poorer areas suffer from poor health conditions, are less educated, have lower income, and limited access to transport and healthcare \[[@B43],[@B44]\]. Moreover, chronic diseases are associated directly or indirectly with disability, as most of the chronically ill patients require special care, diet, and support. Having an amputated limb, for example, makes it very difficult to accomplish the ADL without any help. Twenty-eight percent experienced problems finding work because of amputation \[[@B45]\]. Several factors had a negative impact on reemployment and disability, including but not limited to the amputation level \[[@B46]\], number of amputations \[[@B47]\], comorbidity \[[@B48]\], reason for amputation \[[@B48]\], phantom pain \[[@B48]\], walking distance, and restrictions in mobility \[[@B48]\].

However, "skin ulcer" is inversely linked to physical dependency. In this case, lack of movement (therefore dependency) is the etiology of skin ulcer and not its consequence. This consolidates the summary of a systematic review \[[@B49]\], demonstrating that immobilization and bed rest increased the risk of pressure ulcer development; however, the former can also affect several other organ systems such as the cardiovascular system (orthostatic hypotension, changes in body fluids, reduced oxygen intake, etc.) \[[@B50],[@B51]\], respiratory system (pneumonia, atelectasis, hypoxia) \[[@B50],[@B51]\], musculoskeletal system (muscle atrophy, loss of muscle strength) \[[@B50]\], osteoporosis and bone loss \[[@B51],[@B52]\].

Finally, diet habits were also connected directly or indirectly to the functional status decline. Surprisingly, all types of "healthy" diets (low-fat, sodium-free, etc.) were accompanied by a greater occurrence of disability. In fact, the chronic conditions and diseases leading to the prescription of such diets can be a factor of confusion here. The association of smoking with disability is logical for the effects tobacco has on the nervous system.

For social related variables, we first found that the percentage of disabled individuals was higher among those living with other people than among those living alone, but later loneliness was significantly associated with disability. This finding is expected as independent individuals have a higher possibility of living alone, whereas dependent individuals cannot do it. However, loneliness is well-documented to be associated with a motor decline among community-dwelling older persons \[[@B53],[@B54]\].

The greatest disparity was observed around "alcohol consumption": in both bivariate and multivariate analyses, "drinking alcohol" is proved to be a major factor of dependency with a significant difference between groups. Knowing its physiological properties and social consequences, alcohol can have a direct impact on the functional status decline \[[@B55]\]. However, alcohol and polypharmacy alike may cause hepatotoxicity and can be implicated in some routes leading to disability (drug metabolism, for example). Moreover, alcohol can interact with "depressed mood," "living alone," "smoking," "nutrition," and a multitude of other variables. Alcohol can also increase the risk of falls and potentiates the effect of several medications.

The summary model (applied on the entire sample) has attributed a very small part of the disability to the medications. Only two drug categories remained in the final equation: "PPI" and "anti-gout drugs." This can be explained according to a different hypothesis for PPIs and anti-gout separately. In fact, many disabling conditions, such as the decreased absorption of some minerals (Calcium, Iron, and Magnesium) and vitamins (B12), and the increased risk of cardiovascular events and infections are associated with the use of PPIs \[[@B56]\]. As to anti-gout drugs, the explanation may be the reduced action of one of allopurinol's major active metabolite (oxipurinol) on xanthine oxidase by age. This metabolite, no longer sufficiently active in aged persons, causes disability due to gout-related symptoms and becomes more likely to reappear and to disable the patient \[[@B57]\]. Most other items of the final models are chronic diseases. Interestingly, the effect of polypharmacy, visible in the entire population, has disappeared among people who do not drink alcohol. This reinforces the hypothesis of hepatotoxicity or other "alcohol-drug" interaction; further studies are needed to shed light on this phenomenon.

To our knowledge, this is the first community-based study investigating the functional status in a rural setting. The major strengths of our study include the evaluation of a large sample with a comprehensive assessment of numerous variables potentially linked to the functional status. However, several limitations have to be considered. For some drugs, the number of users was very low; this could lead to a low power of some correlations and wide confidence intervals and hamper the conclusion for some associations. First, the cross-sectional observational study design does not allow drawing causal relationship. Second, although our random sample can be considered as a representative, we cannot perform weighting to provide estimates of prevalence for the entire Lebanese population. Furthermore, potential cognitive disorders, lack of memory, and educational disparities may create some recall bias. In addition, some issues affect the private sphere, and responses to these questions suffer from less reliability. Moreover, most of the health-related information was self-reported. Besides this, several instruments were initially developed in the Western culture and therefore may not be culturally sensitive to Lebanon; this may generate some information bias. Finally, there may be some unrecognized factors and remaining residual bias. We suggest further research that takes into account all these limitations to confirm our findings.

5.. CONCLUSION {#s5}
==============

In summary, the prevalence of disability in our study was 24% and the association of medications with the overall functional status was shown to be multifactorial. The major associations found between medications and disability may be related to both the chronic disease itself and its treatment. However, taking a "Parkinson drug" remained independently a major risk factor of dependency. The other major factors associated with disability were mainly chronic diseases and conditions such as having an amputated limb. Moreover, being a woman, or being poor, older than 80, lonely, depressed, malnourished or thin, smoking, and drinking alcohol increased the chances of being disabled. Most importantly, "alcohol consumption" can affect the association between medication and ADL through hepatotoxicity or any other hypothetical "alcohol-drug" interaction.

In terms of health and social policy, this study has several implications. Appropriate healthcare measures are necessary to reduce the contribution of chronic diseases, as noted by the medication classes taken by each patient, on disability. As socioeconomic status is associated with poorer functional status, it is imperative to ensure pensions for elderly and to guarantee healthcare coverage plans. Moreover, optimal drug prescription with avoidance of unnecessary medications, screening for drug-drug and drug-alcohol interactions and personalization of medication therapy are important measures to take. These practices fall under the responsibility of the pharmacist and other healthcare providers. Finally, the functional status decline in elderly, being a burden on the society: government, families, healthcare providers, and other activists should collaborate to reduce its effect.
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